68.63 USD
-1.37
1.96%
At close Dec 20, 4:00 PM EST
After hours
68.63
+0.00
0.00%
1 day
-1.96%
5 days
-4.98%
1 month
-2.91%
3 months
-8.79%
6 months
2.17%
Year to date
-37.68%
1 year
-36.69%
5 years
-37.85%
10 years
52.78%
 

About: Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Employees: 4,000

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

412% more call options, than puts

Call options by funds: $9.13M | Put options by funds: $1.78M

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

1% less funds holding

Funds holding: 288 [Q2] → 286 (-2) [Q3]

2% less capital invested

Capital invested by funds: $2.49B [Q2] → $2.43B (-$57.8M) [Q3]

5% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 43

6.97% less ownership

Funds ownership: 116.75% [Q2] → 109.78% (-6.97%) [Q3]

16% less repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 109

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$97
41%
upside
Avg. target
$97
41%
upside
High target
$97
41%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Needham
Mike Matson
50% 1-year accuracy
58 / 117 met price target
41%upside
$97
Buy
Reiterated
31 Oct 2024

Financial journalist opinion

Based on 6 articles about CNMD published over the past 30 days

Positive
Zacks Investment Research
1 week ago
Here's Why Conmed (CNMD) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Conmed (CNMD) is a Strong Growth Stock
Neutral
Business Wire
1 week ago
CONMED Corporation Announces Quarterly Cash Dividend
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 9, 2024, payable on January 3, 2025, to all shareholders of record as of December 20, 2024. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties, in.
CONMED Corporation Announces Quarterly Cash Dividend
Neutral
Zacks Investment Research
3 weeks ago
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CNMD is poised for growth on the back of strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Positive
Zacks Investment Research
3 weeks ago
Here's Why Conmed (CNMD) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Conmed (CNMD) is a Strong Value Stock
Positive
Zacks Investment Research
3 weeks ago
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Negative
Benzinga
3 weeks ago
Top 3 Health Care Stocks That May Dip This Month
As of Nov. 25, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Top 3 Health Care Stocks That May Dip This Month
Neutral
Business Wire
1 month ago
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat J. Beyer, Chief Operating Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 12:30 p.m. ET on Tuesday, December 3, 2024. A live video webcast of the fireside chat will be accessible through the “Investors” section of the Company's website at.
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
Positive
Zacks Investment Research
1 month ago
Conmed (CNMD) is a Top-Ranked Momentum Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Conmed (CNMD) is a Top-Ranked Momentum Stock: Should You Buy?
Positive
Zacks Investment Research
1 month ago
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Positive
Zacks Investment Research
1 month ago
Here's Why Conmed (CNMD) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Conmed (CNMD) is a Strong Growth Stock
Charts implemented using Lightweight Charts™